Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma
5 clinical trials · Condition
◉ Watch Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas (NCT03925428) | National Cancer Institute (NCI) | 2020-09-18 |
| Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver Dysfunction (NCT03217253) | National Cancer Institute (NCI) | 2018-03-16 |
| Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas (NCT03198026) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2018-02-20 |
| Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma (NCT02494700) | M.D. Anderson Cancer Center | 2015-07-06 |
Track Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.